Literature DB >> 24801038

[Tumor hypoxia: a key player in the regulation of stromal and anti-tumor responses].

Meriem Hasmim1, Yosra Messai1, Muhammad Zaeem Noman1, Salem Chouaib1.   

Abstract

Hypoxia is a major feature of most solid tumors. Cells adapt to lower oxygen availability by stabilizing HIF transcription factors, which in turn activate the expression of many genes resulting in the survival and maintenance of cellular functions. In tumor cells, exposure to hypoxic stress results in the activation, via the HIF factors, of a series of genes enabling tumor cells to resist to killing by cytotoxic effectors of the immune system. Tissue hypoxia also controls the functions and differentiation of immune cells. This review describes the hypoxia-induced mechanisms of tumor resistance to killing by cytotoxic effectors, and the functional effects of hypoxia on the immune cells.
© 2014 médecine/sciences – Inserm.

Entities:  

Mesh:

Year:  2014        PMID: 24801038     DOI: 10.1051/medsci/20143004017

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  3 in total

1.  Interpretation of immunohistochemistry data of tumor should consider microenvironmental factors.

Authors:  Huan Bian; Shuai Zhang; Huanhuan Wu; Yixiang Wang
Journal:  Tumour Biol       Date:  2015-03-10

2.  Correlation of immunohistochemical expression of HIF-1alpha and IDH1 with clinicopathological and therapeutic data of moroccan glioblastoma and survival analysis.

Authors:  Fatima Sfifou; El Mehdi Hakkou; El Arbi Bouaiti; Meriem Slaoui; Hassan Errihani; Abderrahmane Al Bouzidi; Redouane Abouqal; Abdessamad El Ouahabi; Nadia Cherradi
Journal:  Ann Med Surg (Lond)       Date:  2021-08-17

3.  Keloid-derived keratinocytes acquire a fibroblast-like appearance and an enhanced invasive capacity in a hypoxic microenvironment in vitro.

Authors:  Xiaoyang Ma; Jia Chen; Bei Xu; Xiao Long; Han Qin; Robert Chunhua Zhao; Xiaojun Wang
Journal:  Int J Mol Med       Date:  2015-03-13       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.